Table 3.
Patients with Complications, by Country | All Countries | |||||
---|---|---|---|---|---|---|
Bangladesh (n = 18) | Nepal (n = 12) | Pakistan (n = 60) | With Complications (n = 90) | Without Complications (n = 5115) | P | |
Demographics | ||||||
Age, median (IQR), years | 5 (3–8) | 19 (14–25) | 9 (3–17) | 9 (4–17) | 6 (3–10) | <.001 |
Male gender, n (%) | 8 (44) | 8 (67) | 36 (60) | 52 (58) | 2880 (56) | .78 |
Isolate characteristics | ||||||
S. Typhi serovar, n (%) | 17 (94) | 12 (100) | 58 (97) | 87 (97) | 4516 (88) | .01 |
Fluoroquinolone resistance, n (%) | 18 (100) | 8 (67) | 60 (100) | 86 (96) | 4902 (96) | .82 |
S. Typhi third-generation cephalosporin resistance,a n (%) | 46 (79) | 0 (0) | 0 (0) | 46 (79) | 932 (63) | .01 |
Severity | ||||||
Time from fever onset to hospital presentation, median (IQR), days | 6 (3–8) | 5 (3–8) | 10 (7–16) | 8 (5–14) | 5 (3–7) | <.001 |
Prior antibiotic use,b n (%) | 8 (44) | 8 (67) | 53 (88) | 69 (77) | 2679 (52) | <.001 |
N = 5205.
Abbreviation: IQR, interquartile range.
aPakistan only, where antibiotic resistance testing results were available: n = 58 with complication, n = 1470 without complications; no third-generation cephalosporin resistance was detected in Bangladesh or Nepal.
bPatient or caregiver reported.